Buminate and hepatitis c Patient Reports February 12, 2012



Buminate Side Effects Report #4558376-0
Buminate side effect was reported by a Physician from on Jan 06, 2005. Female patient, 72 years of age, weighting 108.0 lb, was diagnosed with hypoproteinaemia and was treated with Buminate. After drug was administered, patient experienced the following side effects: hepatitis c What is  hepatitis c, indirect infection transmission. Buminate dosage: 100 ML; BID; INTRAVENOUS. During the same period patient was treated with BOLHEAL. Patient recovered.

Buminate Side Effects Report #4597115-4
Buminate side effect was reported by a Physician from on Feb 10, 2005. Female patient, 72 years of age, weighting 108.0 lb, was diagnosed with hypoproteinaemia and was treated with Buminate. After drug was administered, patient experienced the following side effects: hepatitis c What is  hepatitis c, intestinal polyp. Buminate dosage: 100 ML; BID; IJTRAVENOUS. During the same period patient was treated with BOLHEAL. Patient recovered.

Buminate Side Effects Report #5014695-5
Buminate side effect was reported by a Physician from JAPAN on May 10, 2006. Female patient, 72 years of age, weighting 108.0 lb, was diagnosed with hypoproteinaemia and was treated with Buminate. After drug was administered, patient experienced the following side effects: device related infection, haemorrhage, hepatitis c What is  hepatitis c, intestinal polyp. Buminate dosage: 200 ML; ONCE; IV. During the same period patient was treated with BOLHEAL. Patient recovered.
SideEffects101.com does not provide medical advice, diagnosis or treatment. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting SideEffects101.com and reading about

side effects of Buminate